BEFORE THE 

DEPARTMENT OF TRANSPORTATION 

OFFICE OF THE SECRETARY 

WASHINGTON, D.C. 

:AnTMENT OF 

i:^^ORTAT!ON 

'''•> ^,~\r^,-. ':•^ 

nAl 

C;) ... I , A ' > "> 1 

Motion of 

US AIRWAYS, INC. 

for confidential treatment of documents pursuant 

to Rule 12 of the Rules of Practice 

(Schedule B-7 and B-43 of Form 41) 

Docket OST-96-1826 

(former Docket 48735) 

MOTION OF US AIRWAYS, INC. 

FOR CONFIDENTIAL TREATMENT 

Communications with respect to this document should be sent to: 

Howard Kass 

Vice President - Legal and Government Affairs 

Benjamin T. Slocum 

Director and Assistant General Counsel 

US Airways, Inc. 

1401 H Street, NW, Suite 1075 

Washington, DC 20005 

(202)326-5153 

howard.kass@usairways.com 

benj amin. slocum@usairway s .com 

March 30,2012 
BEFORE THE 

DEPARTMENT OF TRANSPORTATION 

OFFICE OF THE SECRETARY 

WASHINGTON, D.C. 

Motion of 

US AIRWAYS, INC. 

for confidential treatment of documents pursuant 

to Rule 12 of the Rules of Practice 

(Schedule B-7 and B-43 of Form 41) 

Docket OST-96-1826 

(former Docket 48735) 

March 30, 2012 

MOTION OF US AIRWAYS, INC. 

FOR CONFIDENTIAL TREATMENT 

Pursuant to Rule 12 of the Department's Rules of Practice (14 C.F.R. §302.12), 

US Airways, Inc. ("US Airways") hereby requests confidential treatment of certain information 

contained in Schedule B-7 - Airframe and Aircraft Engine Acquisitions and Retirements of 

US Airways' Form 41 filing for the quarter ended December 31, 2011 ("Schedule B-7"), and 

Schedule B-43 - Inventory of Airframes and Aircraft Engines for the year ended December 31, 

2011 ("Schedule B-43"). That filing will be submitted separately herewith under seal, marked 

with a request for confidential treatment pursuant to Rule 12 (§ 302.12). US Airways requests 

that these data be withheld from public disclosure for a period of at least ten (10) years from the 

date of their submission. In support of this request, US Airways states as follows: 

The Freedom of Information Act, 5 U.S.C. § 552(b)(4), provides that confidential 

commercial and financial information obtained fi-om a private person is exempt from the 

requirements of public disclosure. The information for which US Airways requests confidential 

treatment is confidential and proprietary commercial and financial information obtained from 

1 
Motion of US Airways, Inc. for Confidential Treatment 

US Airways, a private party. Moreover, the public release of that information would cause US 

Airways substantial competitive and financial injury. Accordingly, the information should be 

withheld from public disclosure. 

The information at issue is cost, amortization/depreciation and realization data relating to 

US Airways' airframes and aircraft engines as of December 31, 2011. This information is 

presented in columns 10, 11, and 12 of Schedule B-7 and in columns 11, 12, 13, 14, and 15 of 

Schedule B-43. See Exhibit A hereto for a listing of the specific information included in 

Schedule B-7 and Schedule B-43 for which confidential treatment is requested. In addition to 

filing Schedule B-7 and Schedule B-43 under seal, US Airways is submitting to the Office of 

Aviation Analysis redacted copies of Schedule B-7 and Schedule B-43, available for public 

inspection, that omit the information for which confidential treatment is requested. 

The Department has previously determined that the confidential and competitivelysensitive data contained in US Airways' Schedules B-7 and B-43 are entitled to confidential 

treatment. By letter of James W. Mitchell, Director, Office of Airline Statistics, the Department 

granted prior US Airways' requests for confidential treatment of this same information for earlier 

reporting periods and ruled that it be withheld from public disclosure for a period of ten (10) 

years. The Department's reasoning applies with equal force to US Airways' present motion and 

submission. 
Motion of US Airways, Inc. for Confidential Treatment 

WHEREFORE, US Airways, Inc. respectfully requests that the confidential 

information contained in its Schedule B-7 and Schedule B-43 detailed above be withheld from 

public disclosure for at least ten (10) years. 

Respectftilly submitted, 

^W^A#-

H^ar d Kass 

Vice President - Legal and Government Affairs 

Benjamin T. Slocum 

Director and Assistant General Counsel 

US Airways, Inc. 

1401 H Street, NW, Suite 1075 

Washington, DC 20005 

(202)326-5153 

howard.kass@usairways.com 

benjamin.slocum@usairways.com 

March 30,2012 
EXHIBIT A 

Listing of Confidential Information in US Airways, Inc.'s Form 41 Filing 

Schedule B-7: 

Title/Description 

Cost 

Depreciated Cost or 

Amortized Value 

Realization 

Location in Document 

Column (10) 

Column (11) 

Column (12) 

Number of Pages 

2 

2 

2 

Schedule B-43: 

Title/Description 

Acquired Cost or Capital 

Value 

Allowance for Depreciation or 

Amortization 

Depreciation Cost or 

Amortized Value 

Estimated Residual Value 

Average Depreciation or 

Amortization Life (Months) 

Location in Document 

Column (11) 

Column (12) 

Column (13) 

Column (14) 

Column (15) 

Number of Pages 

12 

12 

12 

12 

12